Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the best medical AI stocks to buy now. On March 31, Recursion moved to ...

Short sellers are concentrating their bets heavily in the small-cap space as of mid-April, with healthcare, and biotechnology in particular, drawing the most attention. The following list ranks the 10 ...

OpenAI is rolling out an early version of an artificial intelligence model designed to accelerate drug discovery, joining a ...

Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.60, marking a -4% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.26%.

Each Strixhaven college gets their own dedicated ability. Silverquill's is repartee, which triggers whenever you play an ...

According to TipRanks.com, Blum is a 4-star analyst with an average return of 9.1% and a 40.2% success rate. Blum covers the Healthcare sector, focusing on stocks such as Artiva Biotherapeutics, Inc., ...

Recursion Pharmaceuticals executives discussed the company’s artificial intelligence-driven drug discovery platform during a ...

View Recursion Pharmaceuticals, Inc. Class A RXRX stock quote prices, financial information, real-time forecasts, and company news from CNN.

Generic formats like JSON or XML are easier to version than forms. However, they were not originally intended to be ...

Recursion Pharmaceuticals expanded its collaboration with Citeline to integrate real world data into its AI enabled ClinTech Platform. The partnership is aimed at refining clinical trial design and ...

The more we rely on AI, without oversight or validation, the greater our exposure is to making critical decisions based on ...